Treace Medical Concepts Inc

Treace Medical Concepts, Inc. is a medical technology company focused on the surgical treatment of bunions and related foot deformities. The company has pioneered the Lapiplasty 3D Bunion Correction System, a combination of instruments, implants, and surgical methods designed to correct all three planes of bunion deformity and secure the unstable joint that causes bunions, addressing the root cause rather than just cosmetic correction. The company estimates approximately 67 million Americans are affected by bunions, with 1.1 million being annual surgical candidates. Treace's product portfolio has expanded to include the Adductoplasty Midfoot Correction System for midfoot deformities, the Nanoplasty 3D Minimally Invasive Bunion Correction System and Percuplasty Percutaneous 3D Bunion Correction System for minimally invasive osteotomy procedures, the SpeedMTP MTP Fusion System, the SpeedPlate rapid compression implant platform, the IntelliGuide patient-specific pre-op planning and cut guide technology, the SuperBite fully-threaded compression screws for fusions throughout the foot, and the HyperPlate XM Dynamic Compression Locking Implant System. The company sells its products in the United States and trades on the Nasdaq Global Select Market under the ticker TMCI. Updated Aug 7, 2026